Results 61 to 70 of about 116,563 (168)

Arctigenin Suppresses Breast Cancer Growth In Vitro and In Vivo Through Subtype-Specific Multi-Targeting Activity. [PDF]

Int J Mol Sci
Yang J, Hao Q, Wu K, Elshimali Y, Andalibi A, Wang P.   +5 more
europepmc   +1 more source

Anticancer Potential of Thiocolchicoside: An In-Vitro MTT Assay Study. [PDF]

Cureus
Devi AV, Khanwelkar C.
europepmc   +1 more source

Auditions MCF 2020

Sine lege, 2020
openaire   +2 more sources

Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation. [PDF]

Int J Mol Sci
Muñoz-Ayala A, Serafín-Higuera N, Leija-Montoya AG, Galindo-Hernández O, Vique-Sánchez JL, Díaz-Molina R, Villafaña S, García-González V.   +7 more
europepmc   +1 more source

Auditions MCF

Sine lege, 2015
openaire   +2 more sources

Recrutement MCF 2020

Empire russe, URSS et monde post-soviétique, 2020
openaire   +2 more sources

A Case of Acquired Pars Flaccida Cholesteatoma Extending to the Supralabyrinthine Petrous Apex With Preservation of the Otic Capsule. [PDF]

Case Rep Otolaryngol
Sugimoto H, Inaba M, Nagasaki G, Yoshizaki T.   +3 more
europepmc   +1 more source

Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway. [PDF]

Oncol Rep
Feng H, He L, Umar T, Wang H, Gao Y, Chen G, Sun P, Yin L, Zhao W, Lu H, Deng G, Qiu C.   +11 more
europepmc   +1 more source

Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells. [PDF]

PLoS One
Rujimongkon K, Adchariyasakulchai P, Boonyaratsewee C, Horpratraporn K, Ketchart W.   +4 more
europepmc   +1 more source

BILLARD Henri (MCF)

, 2023
openaire   +1 more source